Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • Worldwide Psychedelic Laws
    • U.S. Psychedelic Policy Reform
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Psychedelic Funding Update: Q1 2025

Psychedelic Funding Update: Q1 2025

  • Post published:April 22, 2025
  • Post category:Analysis/Pα+
Read more about the article High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

High Hopes in the Mile High City: Inside Colorado’s First Licensed Psilocybin Center

  • Post published:April 17, 2025
  • Post category:Analysis/News
Read more about the article Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape

Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape

  • Post published:April 9, 2025
  • Post category:Analysis/News/Pα+
Read more about the article BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

  • Post published:April 8, 2025
  • Post category:Analysis/News
Read more about the article March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

  • Post published:April 7, 2025
  • Post category:Analysis/News/Pα+
Read more about the article Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

Transcend Posts Positive Phase 2 Data from Methylone for PTSD Program

  • Post published:March 31, 2025
  • Post category:Analysis/News/Pα+
Read more about the article Beyond Guinea Pigs: Ensuring Access to Psychedelic Therapies for Europeans

Beyond Guinea Pigs: Ensuring Access to Psychedelic Therapies for Europeans

  • Post published:March 25, 2025
  • Post category:Analysis/News
Read more about the article Behind the Scenes of the “Psychedelic Renaissance” at SXSW 2025

Behind the Scenes of the “Psychedelic Renaissance” at SXSW 2025

  • Post published:March 14, 2025
  • Post category:Analysis/News/Pα+
Read more about the article A Rundown of Colorado’s Natural Medicine Program

A Rundown of Colorado’s Natural Medicine Program

  • Post published:March 5, 2025
  • Post category:Analysis/Colorado Natural Medicine Advisory Bulletin/News
Read more about the article Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States

Psychedelic Policy Push Continues: Over 60 Bills Introduced Across 22 States

  • Post published:February 27, 2025
  • Post category:Analysis/News/Pα+

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More